Long-term Effects of MVPP Chemotherapy on Bone Marrow Function in Hodgkin's Disease
Author Information
Author(s): J.A. Radford, N.G. Testa, D. Crowther
Primary Institution: CRC Department of Medical Oncology, Christie Hospital
Hypothesis
Does MVPP chemotherapy for Hodgkin's disease impair bone marrow function long-term?
Conclusion
Patients treated with MVPP chemotherapy show evidence of impaired bone marrow function even years after treatment.
Supporting Evidence
- Bone marrow function was significantly lower in patients treated with MVPP compared to controls.
- Median GM-CFC scores were 69 for controls and 17 for post-MVPP patients.
- Adherent layer formation in long-term cultures was significantly less in post-MVPP patients.
Takeaway
This study found that even after patients with Hodgkin's disease finish their chemotherapy, their bone marrow might not work as well as it should.
Methodology
In vitro techniques were used to study bone marrow function in patients who had completed MVPP chemotherapy.
Limitations
The study only included patients who were in complete remission and did not assess the long-term effects on all patients.
Participant Demographics
25 patients, 10 male and 15 female, median age 28 years.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website